Cardiology

Switching dual antiplatelet therapy beneficial after ACS

(HealthDay)—Switching dual antiplatelet therapy (DAPT) from aspirin plus ticagrelor or prasugrel to aspirin plus clopidogrel after acute coronary syndrome (ACS) provides benefits regardless of initial platelet reactivity, ...

Cardiology

Serial hsTnT level IDs risk of 30-day adverse cardiac event

(HealthDay)—High-sensitivity troponin (hsTnT) assay can identify patients presenting with suspected acute coronary syndrome at very low risk for 30-day adverse cardiac events (ACE), according to a study published online ...

Cardiology

AHA: Cardiac troponin I IDs low risk of MI, cardiac death

(HealthDay)—High-sensitivity cardiac troponin I concentration can identify individuals at low risk of myocardial infarction or cardiac death within 30 days among patients with suspected acute coronary syndrome, according ...

Cardiology

CYP2C19-genotype guided antiplatelet tx may be beneficial

(HealthDay)—Patients with a CYP2C19 loss-of-function allele have increased risk of major adverse cardiovascular events (MACE) with clopidogrel versus alternative antiplatelet therapy after percutaneous coronary intervention ...

page 12 from 29